Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

10.1038/s41525-018-0058-3

Saved in:

Bibliographic Details
Main Authors:	Lawrence, B, Blenkiron, C, Parker, K
Other Authors:	SURGERY
Format:	Article
Published:	2020
Subjects:	BRCA2 protein CD56 antigen chromogranin A cyclin dependent kinase inhibitor 1B DNA glycosylase MutY DNA mismatch repair protein MSH2 fibroblast growth factor receptor 3 Janus kinase 2 messenger RNA phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase RNA synaptophysin von Hippel Lindau protein aneuploidy Article cancer prognosis cancer susceptibility carcinogenesis cell differentiation chromosome 11 clinical outcome disease severity flcn gene gene gene expression gene mutation genetic variability heterozygosity loss human human tissue major clinical study men1 gene microarray analysis New Zealand pancreas islet cell tumor priority journal progression free survival RNA methylation single nucleotide polymorphism whole genome sequencing
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/177814
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Be the first to leave a comment!